GTS Securities’s Eli Lilly LLY Stock Holding History

GTS Securities’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.42M	Sell	3,719 -4,427	-54%	-$4.49M	0.12%	112
2025 Q4	$8.75M	Buy	8,146 +3,571	+78%	+$3.41M	0.3%	42
2025 Q3	$3.49M	Buy	4,575 +1,319	+41%	+$982K	0.13%	122
2025 Q2	$2.54M	Sell	3,256 -5,100	-61%	-$3.96M	0.11%	138
2025 Q1	$6.9M	Buy	8,356 +4,217	+102%	+$3.51M	0.3%	42
2024 Q4	$3.2M	Sell	4,139 -12,420	-75%	-$10.3M	0.16%	104
2024 Q3	$14.7M	Buy	16,559 +1,891	+13%	+$1.7M	0.03%	359
2024 Q2	$13.3M	Buy	14,668 +13,585	+1,254%	+$10.9M	0.03%	388
2024 Q1	$843K	Sell	1,083 -15,162	-93%	-$10.8M	﹤0.01%	2120
2023 Q4	$9.47M	Buy	16,245 +9,526	+142%	+$5.56M	0.02%	637
2023 Q3	$3.61M	Buy	+6,719	New	+$3.46M	0.01%	1120

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GTS Securities's LLY Position: Q1 2026 in Review

GTS Securities reduced its Eli Lilly (LLY) stake by 54% in Q1 2026, selling an estimated $4.49M and leaving 3,719 shares worth $3.42M. The position accounts for 0.12% of the portfolio, ranked #112.

GTS Securities first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $14.7M in Q3 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

GTS Securities held 3,719 shares of Eli Lilly worth $3.42M as of Q1 2026.
GTS Securities sold 4,427 Eli Lilly shares in Q1 2026, an estimated $4.49M.
Eli Lilly made up 0.12% of GTS Securities's portfolio in Q1 2026, its #112 holding.
GTS Securities first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
GTS Securities's Eli Lilly position peaked at $14.7M in Q3 2024.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.